Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T17:32:29.257Z.
Calculation as of: 2026-10-06T17:32:29.257Z.
Quote observation: 2026-10-06T17:30:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 764f42141b21779aba3712b54ee9373bee46ed3fd4a49ef41b5b57d04fae8ed9
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$236.81M
Free Cash Flow Yield
4.84%
TTM Avg
5.58%
3Y Avg
6.49%
5Y Avg
6.20%
Market Cap
$236.25M
Free Cash Flow Yield
17.00%
TTM Avg
15.02%
3Y Avg
15.02%
5Y Avg
15.02%
Market Cap
$238.40M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$239.00M
Free Cash Flow Yield
N/A
TTM Avg
12.33%
3Y Avg
12.33%
5Y Avg
12.33%
Market Cap
$239.09M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$235.26M
Free Cash Flow Yield
N/A
TTM Avg
17.89%
3Y Avg
12.79%
5Y Avg
11.00%
Market Cap
$241.31M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Invivyd, Inc. (IVVD) | $237.31M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $236.81M | 4.84% | 5.58% | 6.49% | 6.20% |
| InflaRx N.V. (IFRX)vs › | $236.41M | N/A | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $236.25M | 17.00% | 15.02% | 15.02% | 15.02% |
| Galectin Therapeutics Inc. (GALT)vs › | $238.40M | N/A | N/A | N/A | N/A |
| Q32 Bio Inc. (QTTB)vs › | $239.00M | N/A | 12.33% | 12.33% | 12.33% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $239.09M | N/A | N/A | N/A | N/A |
| SIGA Technologies, Inc. (SIGA)vs › | $235.26M | N/A | 17.89% | 12.79% | 11.00% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $241.31M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.50M | N/A | 1.67% | 1.64% | 2.28% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
